Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children.

• Main Authors: Gilles Riveau (Author), Anne-Marie Schacht (Author), Jean-Pierre Dompnier (Author), Dominique Deplanque (Author), Modou Seck (Author), Nawal Waucquier (Author), Simon Senghor (Author), Delphine Delcroix-Genete (Author), Emmanuel Hermann (Author), Noureddine Idris-Khodja (Author), Claire Levy-Marchal (Author), Monique Capron (Author), André Capron (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2018-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<h4>Background</h4>Urinary schistosomiasis, the result of infection by Schistosoma haematobium (Sh), remains a major global health concern. A schistosome vaccine could represent a breakthrough in schistosomiasis control strategies, which are presently based on treatment with praziquantel...